Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-02-03 @ 3:47 PM
Study NCT ID:
NCT00567359
Status:
COMPLETED
Last Update Posted:
2018-12-11
First Post:
2007-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
Sponsor:
Massachusetts General Hospital
Organization: